InvestorsHub Logo
Followers 19
Posts 815
Boards Moderated 0
Alias Born 02/24/2014

Re: ATLnsider post# 586485

Tuesday, 04/18/2023 2:22:39 PM

Tuesday, April 18, 2023 2:22:39 PM

Post# of 687573
I would doubt that would be a scenerio. If you research poly-ICLC It is being used as an adjuvant in MANY studies. Including HIV studies. The potential uses are unlimited in regard to immuno therapeutics Though what a beautiful company it would make. I believe Oncovir is also a private company. I think it would never be a merger. An acquisition down the road, who knows. Currently over 100 studies using HILTONOL (poly-ICLC) This company would likely pack a big punch in regard to $$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News